{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:27:43Z","timestamp":1794061663754,"version":"4.8.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20222KSN2N"],"award-info":[{"award-number":["20222KSN2N"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12376821"],"award-info":[{"award-number":["PNRR-MR1-2022-12376821"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["SG-2019-12368589"],"award-info":[{"award-number":["SG-2019-12368589"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RF-2019-12369105"],"award-info":[{"award-number":["RF-2019-12369105"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tem.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T09:10:58Z","timestamp":1742029858000},"page":"1029-1042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hidden players in the metabolic vulnerabilities of amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Marco","family":"Rosina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scaricamazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Fenili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-0903","authenticated-orcid":false,"given":"Maria Paola","family":"Paronetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2025.02.004_bb0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2025.02.004_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in ALS","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tem.2025.02.004_bb0015","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2025.02.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024117","article-title":"Clinical spectrum of amyotrophic lateral sclerosis (ALS)","volume":"7","author":"Grad","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tem.2025.02.004_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainresbull.2020.03.012","article-title":"In vitro and in vivo models of amyotrophic lateral sclerosis: an updated overview","volume":"159","author":"Gois","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tem.2025.02.004_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bmb\/ldw026","article-title":"Pathogenesis of amyotrophic lateral sclerosis","volume":"119","author":"Morgan","year":"2016","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.tem.2025.02.004_bb0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/B978-0-444-64076-5.00039-9","article-title":"Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis","volume":"148","author":"Goutman","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/cells12111523","article-title":"Current state and future directions in the therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.tem.2025.02.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117257","article-title":"Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects","volume":"420","author":"Fayemendy","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tem.2025.02.004_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ene.13468","article-title":"Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis","volume":"25","author":"J\u00e9sus","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0055","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","article-title":"Hypermetabolism in ALS is associated with greater functional decline and shorter survival","volume":"89","author":"Steyn","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tem.2025.02.004_bb0060","article-title":"Mapping the evidence for measuring energy expenditure and indicating hypermetabolism in motor neuron disease: a scoping review","author":"Roscoe","year":"2024","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.tem.2025.02.004_bb0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/CPJ.0000000000000521","article-title":"Body mass index and survival from amyotrophic lateral sclerosis: a meta-analysis","volume":"8","author":"Dardiotis","year":"2018","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.tem.2025.02.004_bb0070","doi-asserted-by":"crossref","first-page":"13292","DOI":"10.1038\/s41598-022-16229-9","article-title":"Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2025.02.004_bb0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/WCO.0000000000001164","article-title":"Abnormal energy metabolism in ALS: a key player?","volume":"36","author":"Burg","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104521","article-title":"Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers","volume":"90","author":"Dorst","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2025.02.004_bb0085","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/bph.15738","article-title":"Repurposing of trimetazidine for amyotrophic lateral sclerosis: a study in SOD1","volume":"179","author":"Scaricamazza","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tem.2025.02.004_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/cells10030525","article-title":"Skeletal muscle in ALS: an unappreciated therapeutic opportunity?","volume":"10","author":"Scaricamazza","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tem.2025.02.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103397","article-title":"Physical exercise is a risk factor for amyotrophic lateral sclerosis: convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes","volume":"68","author":"Julian","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2025.02.004_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/21678421.2021.1910308","article-title":"History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010-2018","volume":"22","author":"Raymond","year":"2021","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"10.1016\/j.tem.2025.02.004_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1421566","article-title":"Physical exercise in amyotrophic lateral sclerosis: a potential co-adjuvant therapeutic option to counteract disease progression","volume":"12","author":"Fenili","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tem.2025.02.004_bb0110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3389\/fphys.2019.01537","article-title":"Tailored exercise training counteracts muscle disuse and attenuates reductions in physical function in individuals with amyotrophic lateral sclerosis","volume":"10","author":"Ferri","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tem.2025.02.004_bb0115","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1007\/s10072-024-07508-6","article-title":"Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches","volume":"45","author":"Kubat","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.tem.2025.02.004_bb0120","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1093\/brain\/awad202","article-title":"Skeletal muscle in amyotrophic lateral sclerosis","volume":"146","author":"Shefner","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tem.2025.02.004_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","article-title":"CNS glucose metabolism in amyotrophic lateral sclerosis: a therapeutic target?","volume":"11","author":"Tefera","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tem.2025.02.004_bb0130","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","article-title":"Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia","volume":"32","author":"Peter","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.tem.2025.02.004_bb0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/jnnp-2017-315795","article-title":"Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis","volume":"88","author":"Gorges","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tem.2025.02.004_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/ene.15589","article-title":"Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis","volume":"30","author":"Chang","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0145","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209603","article-title":"Association between hypothalamic volume and metabolism, cognition, and behavior in patients with amyotrophic lateral sclerosis","volume":"103","author":"Michielsen","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2025.02.004_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14801","article-title":"Volume loss in the left anterior-superior subunit of the hypothalamus in amyotrophic lateral sclerosis","volume":"30","author":"Ghaderi","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.tem.2025.02.004_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s40478-014-0171-1","article-title":"TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis","volume":"2","author":"Cykowski","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tem.2025.02.004_bb0160","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00401-023-02569-x","article-title":"Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis","volume":"145","author":"Bolborea","year":"2023","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2025.02.004_bb0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/nan.12709","article-title":"Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis","volume":"47","author":"Gabery","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tem.2025.02.004_bb0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3233\/NRE-161357","article-title":"Swallowing characteristics in amyotrophic lateral sclerosis","volume":"39","author":"Jani","year":"2016","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.tem.2025.02.004_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1193483","article-title":"Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders","volume":"15","author":"Gnoni","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tem.2025.02.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16052","article-title":"Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis","volume":"31","author":"Howe","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0185","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1468-1331.2009.02896.x","article-title":"The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features","volume":"17","author":"Pellecchia","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2006.02609.x","article-title":"Growth hormone secretion is impaired in amyotrophic lateral sclerosis","volume":"65","author":"Morselli","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2025.02.004_bb0195","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1210\/en.2011-2171","article-title":"Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis","volume":"153","author":"Steyn","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2025.02.004_bb0200","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1210\/en.2013-1570","article-title":"Growth hormone secretion is correlated with neuromuscular innervation rather than motor neuron number in early-symptomatic male amyotrophic lateral sclerosis mice","volume":"154","author":"Steyn","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2025.02.004_bb0205","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","article-title":"Subcutaneous IGF-1 is not beneficial in 2-year ALS trial","volume":"71","author":"Sorenson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2025.02.004_bb0210","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41598-020-57744-x","article-title":"Association of insulin-like growth factor 1 concentrations with risk for and prognosis of amyotrophic lateral sclerosis - results from the ALS Registry Swabia","volume":"10","author":"Nagel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2025.02.004_bb0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200407021","article-title":"Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model","volume":"168","author":"Dobrowolny","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tem.2025.02.004_bb0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/174313208X281235","article-title":"Local expression of mIgf-1 modulates ubiquitin, caspase and CDK5 expression in skeletal muscle of an ALS mouse model","volume":"30","author":"Dobrowolny","year":"2008","journal-title":"Neurol. Res."},{"key":"10.1016\/j.tem.2025.02.004_bb0225","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.tem.2025.02.004_bb0230","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1038\/s41598-024-67165-9","article-title":"Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression","volume":"14","author":"Femiano","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2025.02.004_bb0235","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1111\/bph.15665","article-title":"The feeding behaviour of amyotrophic lateral sclerosis mouse models is modulated by the Ca","volume":"178","author":"Cocozza","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tem.2025.02.004_bb0240","first-page":"1284","article-title":"Sleep disturbances in amyotrophic lateral sclerosis and prognostic impact \u2013 a retrospective study","volume":"14","author":"Silva","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.tem.2025.02.004_bb0245","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/biom13050863","article-title":"Evidence of metabolic dysfunction in amyotrophic lateral sclerosis (ALS) patients and animal models","volume":"13","author":"Maksimovic","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.tem.2025.02.004_bb0250","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1172\/JCI124481","article-title":"TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets","volume":"129","author":"Araki","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2025.02.004_bb0255","article-title":"Glucose clearance and uptake is increased in the SOD1","volume":"35","author":"McDonald","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2025.02.004_bb0260","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ana.27115","article-title":"Fighting amyotrophic lateral sclerosis by protecting the liver? A prospective cohort study","volume":"97","author":"Zhu","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0265","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/genes13060936","article-title":"Nonalcoholic fatty liver disease in patients with inherited and sporadic motor neuron degeneration","volume":"13","author":"Johnson","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.tem.2025.02.004_bb0270","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41582-023-00845-8","article-title":"Nutritional and metabolic factors in amyotrophic lateral sclerosis","volume":"19","author":"Ludolph","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0275","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2025.02.004_bb0280","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41598-022-05714-w","article-title":"Investigation of the prognostic predictive value of serum lipid profiles in amyotrophic lateral sclerosis: roles of sex and hypermetabolism","volume":"12","author":"Nakamura","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2025.02.004_bb0285","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1007\/s00415-023-11630-4","article-title":"Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry","volume":"270","author":"Michels","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0290","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1007\/s00415-024-12665-x","article-title":"Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study","volume":"271","author":"Chalitsios","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0295","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","article-title":"Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis","volume":"258","author":"Dorst","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0300","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms19051308","article-title":"Insulin-like growth factor (IGF) system in liver diseases","volume":"19","author":"Adamek","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2025.02.004_bb0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.14740\/jocmr2761w","article-title":"Insulin-like growth factor-1 deficiency and cirrhosis establishment","volume":"9","author":"de la Garza","year":"2017","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.tem.2025.02.004_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126263","article-title":"Effects and potential mechanisms of IGF1\/IGF1R in the liver fibrosis: a review","volume":"251","author":"Gui","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tem.2025.02.004_bb0315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00314034","article-title":"Functional and morphometric study of the liver in motor neuron disease","volume":"232","author":"Masui","year":"1985","journal-title":"J. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022374","article-title":"Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS","volume":"6","author":"Finkelstein","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2025.02.004_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090449","article-title":"Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models","volume":"9","author":"Perera","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2025.02.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101087","article-title":"Skeletal-muscle metabolic reprogramming in ALS-SOD1","volume":"23","author":"Scaricamazza","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.tem.2025.02.004_bb0335","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.02.035","article-title":"Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis","volume":"340","author":"Ngo","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tem.2025.02.004_bb0340","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1212\/WNL.0000000000007861","article-title":"High BMI is associated with low ALS risk: a population-based study","volume":"93","author":"Nakken","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2025.02.004_bb0345","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ana.25671","article-title":"Life course adiposity and amyotrophic lateral sclerosis: a Mendelian randomization study","volume":"87","author":"Zhang","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0350","article-title":"Reassessing human adipose tissue","volume":"386","author":"Buti","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2025.02.004_bb0355","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbrc.2010.02.029","article-title":"Human adipose-derived stem cells enhance the glutamate uptake function of GLT1 in SOD1(G93A)-bearing astrocytes","volume":"393","author":"Gu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2025.02.004_bb0360","article-title":"Mesenchymal stem cells for neurological disorders","volume":"8","author":"Andrzejewska","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.tem.2025.02.004_bb0365","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s11064-015-1774-z","article-title":"Neuroprotective effect of human adipose stem cell-derived extract in amyotrophic lateral sclerosis","volume":"41","author":"Jeon","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tem.2025.02.004_bb0370","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3727\/096368913X673450","article-title":"Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model","volume":"23","author":"Kim","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.tem.2025.02.004_bb0375","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbrc.2015.03.118","article-title":"ALS-associated P56S-VAPB mutation restrains 3T3-L1 preadipocyte differentiation","volume":"460","author":"Tokutake","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2025.02.004_bb0380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainresbull.2022.06.008","article-title":"Delayed onset, immunomodulation, and lifespan improvement of SOD1","volume":"186","author":"Chiarotto","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tem.2025.02.004_bb0385","article-title":"Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: exploring the utility of dual-energy X-ray absorptiometry in a prospective study","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2025.02.004_bb0390","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3390\/ijms21103651","article-title":"ASC-exosomes ameliorate the disease progression in SOD1(G93A) murine model underlining their potential therapeutic use in human ALS","volume":"21","author":"Bonafede","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2025.02.004_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4392017","article-title":"Intraspinal transplantation of the adipose tissue-derived regenerative cells in amyotrophic lateral sclerosis in accordance with the current experts\u2019 recommendations: choosing optimal monitoring tools","volume":"2018","author":"Kuzma-Kozakiewicz","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.tem.2025.02.004_bb0400","first-page":"772","article-title":"Safety and efficacy of allogeneic adipose tissue mesenchymal stromal cells in amyotrophic lateral sclerosis patients, single-center, prospective, open-label, single-arm clinical trial, long-term follow-up","volume":"23","author":"Nabavi","year":"2021","journal-title":"Cell J."},{"key":"10.1016\/j.tem.2025.02.004_bb0405","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180073","article-title":"Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations","volume":"134","author":"Mauvais-Jarvis","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2025.02.004_bb0410","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1007\/s12035-016-0322-4","article-title":"Administration of 17\u03b2-estradiol improves motoneuron survival and down-regulates inflammasome activation in male SOD1(G93A) ALS mice","volume":"54","author":"Heitzer","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2025.02.004_bb0415","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endrev\/bnz005","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2025.02.004_bb0420","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.brainresbull.2017.05.016","article-title":"Characterization of aromatase expression in the spinal cord of an animal model of familial ALS","volume":"132","author":"Sun","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tem.2025.02.004_bb0425","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mus.27942","article-title":"Exposure to endogenous and exogenous sex hormones and reproductive history influence prognosis in women with ALS","volume":"68","author":"Gonzalez Deniselle","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tem.2025.02.004_bb0430","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000516344","article-title":"Reproductive history and age of onset for women diagnosed with amyotrophic lateral sclerosis: data from the National ALS Registry: 2010-2018","volume":"55","author":"Raymond","year":"2021","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tem.2025.02.004_bb0435","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s12020-024-03755-x","article-title":"Neuroactive steroids in the neuroendocrine control of food intake, metabolism, and reproduction","volume":"85","author":"Rasic-Markovic","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2025.02.004_bb0440","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/hmg\/ddx049","article-title":"Sex specific activation of the ER\u03b1 axis of the mitochondrial UPR (UPRmt) in the G93A-SOD1 mouse model of familial ALS","volume":"26","author":"Riar","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2025.02.004_bb0445","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-015-0271-6","article-title":"Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS","volume":"4","author":"Cacabelos","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tem.2025.02.004_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.749451","article-title":"Mitochondria in sex hormone-induced disorder of energy metabolism in males and females","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2025.02.004_bb0455","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI125316","article-title":"ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes","volume":"129","author":"Ducasa","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2025.02.004_bb0460","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s12035-020-02209-5","article-title":"Neuroprotective effects of testosterone in male wobbler mouse, a model of amyotrophic lateral sclerosis","volume":"58","author":"Lara","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2025.02.004_bb0465","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.25661","article-title":"Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis","volume":"87","author":"Ludolph","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2025.02.004_bb0470","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-021-00241-6","article-title":"Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients","volume":"10","author":"Bayer","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tem.2025.02.004_bb0475","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/brain\/aww004","article-title":"Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis","volume":"139","author":"Vercruysse","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tem.2025.02.004_bb0480","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neurol.2019.09.008","article-title":"The effects of diet and sex in amyotrophic lateral sclerosis","volume":"176","author":"Pape","year":"2020","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.tem.2025.02.004_bb0485","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41598-024-52439-z","article-title":"Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1","volume":"14","author":"Fern\u00e1ndez-Beltr\u00e1n","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2025.02.004_bb0490","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neures.2021.11.003","article-title":"Decreased plasma ghrelin in male ALS patients is associated with poor prognosis","volume":"177","author":"Nagaoka","year":"2022","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.tem.2025.02.004_bb0495","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2015.06.053","article-title":"Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis","volume":"357","author":"Ngo","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tem.2025.02.004_bb0500","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","article-title":"Leptin as a key regulator of the adipose organ","volume":"23","author":"Pic\u00f3","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.tem.2025.02.004_bb0505","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30526","article-title":"Metformin ameliorates mitochondrial damage induced by C9orf72 poly(GR) via upregulating AKT phosphorylation","volume":"125","author":"Feng","year":"2024","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.tem.2025.02.004_bb0510","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/cn300110c","article-title":"Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo","volume":"3","author":"Morales-Garcia","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tem.2025.02.004_bb0515","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1007\/s11033-023-08650-8","article-title":"Modulating cyclic nucleotides pathways by bioactive compounds in combatting anxiety and depression disorders","volume":"50","author":"Guti\u00e9rrez-Rodelo","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tem.2025.02.004_bb0520","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2025.02.004_bb0525","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041479","article-title":"Study protocol of RESCUE-ALS: a phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression","volume":"11","author":"Vucic","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.tem.2025.02.004_bb0530","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphys.2019.00897","article-title":"Metabolic reprogramming promotes myogenesis during aging","volume":"10","author":"Belli","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tem.2025.02.004_bb0535","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jcsm.12226","article-title":"The mitochondrial metabolic reprogramming agent trimetazidine as an \u2018exercise mimetic\u2019 in cachectic C26-bearing mice","volume":"8","author":"Molinari","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.tem.2025.02.004_bb0540","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/mus.27560","article-title":"Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis","volume":"66","author":"Chandrashekhar","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tem.2025.02.004_bb0545","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model","volume":"101","author":"Dupuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2025.02.004_bb0550","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","article-title":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders","volume":"483","author":"Agarwal","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2025.02.004_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS One"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327602500044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327602500044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:18:36Z","timestamp":1766071116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104327602500044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":111,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S104327602500044X"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2025.02.004","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidden players in the metabolic vulnerabilities of amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}